Chronic lymphoid leukemia
Clinical trials for Chronic lymphoid leukemia explained in plain language.
Never miss a new study
Get alerted when new Chronic lymphoid leukemia trials appear
Sign up with your email to follow new studies for Chronic lymphoid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Four-Drug cocktail erase traces of Hard-to-Treat leukemia?
Disease control OngoingThis phase 2 trial is testing whether a sequence of four drugs—bendamustine, obinutuzumab, zanubrutinib, and venetoclax—can eliminate minimal residual disease in people with relapsed or refractory chronic lymphocytic leukemia (CLL). The study enrolls about 42 adults whose CLL has…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase 2 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Major CLL trial tests which drug combo works best for new patients
Disease control OngoingThis phase 3 trial compares three treatment approaches for people with previously untreated chronic lymphocytic leukemia (CLL): continuous ibrutinib alone, a fixed-duration combination of venetoclax plus obinutuzumab, or a fixed-duration combination of ibrutinib plus venetoclax. …
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase 3 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug shows promise in Early-Stage High-Risk leukemia trial
Disease control OngoingThis phase II trial tests the drug venetoclax as an early treatment for people with high-risk chronic lymphocytic leukemia (CLL) that hasn't caused symptoms yet. About 82 participants will take venetoclax daily for up to 18 months. The goal is to see if the drug can wipe out near…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase 2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC